Received Feb 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | EL3302 | SYR / LA |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | EL9264 | SYR / LA |
Adverse Event: 1.Massive Heart Attack in Proximal Circumflex Artery Segment -. Treatment: 1. Coronary angiogram 2. Percutaneous transluminal angioplasty and primary intracoronary stent placement to the CxOM and balloon angioplasty of the Cx 3. Intravascular ultrasound of the Cx-OM
none
none
none
none
CV COR ANGIO, 11.21.2021 CV IVUS/OCT, 11.21.2021 CV STENT, 11.21.2021